Pre-emptive Daratumumab Therapy of Minimal Residual Disease Reappearance or Biochemical Relapse in Multiple Myeloma
Clinical trial NCT03697655 · UNKNOWN
Trial details
- NCT number
- NCT03697655
- Sponsor
- Polish Myeloma Consortium
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-10
- Primary completion
- 2020-09-01
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.